TW201339578A - 在低傳導率下具有增加之靈敏度的自體抗體測量 - Google Patents

在低傳導率下具有增加之靈敏度的自體抗體測量 Download PDF

Info

Publication number
TW201339578A
TW201339578A TW101147349A TW101147349A TW201339578A TW 201339578 A TW201339578 A TW 201339578A TW 101147349 A TW101147349 A TW 101147349A TW 101147349 A TW101147349 A TW 101147349A TW 201339578 A TW201339578 A TW 201339578A
Authority
TW
Taiwan
Prior art keywords
conductivity
less
sodium chloride
chloride solution
autoantibody
Prior art date
Application number
TW101147349A
Other languages
English (en)
Chinese (zh)
Inventor
Alfred Weber
Andrea Engelmaier
Hans-Peter Schwarz
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of TW201339578A publication Critical patent/TW201339578A/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
TW101147349A 2011-12-13 2012-12-13 在低傳導率下具有增加之靈敏度的自體抗體測量 TW201339578A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161570211P 2011-12-13 2011-12-13

Publications (1)

Publication Number Publication Date
TW201339578A true TW201339578A (zh) 2013-10-01

Family

ID=47630506

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101147349A TW201339578A (zh) 2011-12-13 2012-12-13 在低傳導率下具有增加之靈敏度的自體抗體測量

Country Status (14)

Country Link
US (1) US9075069B2 (pl)
EP (1) EP2791675B1 (pl)
JP (1) JP6333731B2 (pl)
KR (1) KR20140104479A (pl)
AR (1) AR089233A1 (pl)
AU (1) AU2012321074B2 (pl)
DK (1) DK2791675T3 (pl)
ES (1) ES2685332T3 (pl)
HR (1) HRP20181118T1 (pl)
HU (1) HUE038441T2 (pl)
PL (1) PL2791675T3 (pl)
PT (1) PT2791675T (pl)
TW (1) TW201339578A (pl)
WO (1) WO2013090636A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013203043B2 (en) * 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
US20160168235A1 (en) * 2013-07-19 2016-06-16 Board Of Regents Of The University Of Texas System Transthyretin amyloid-selective and polyreactive catabodies
SI24638A (sl) * 2014-02-04 2015-08-31 Univerzitetni kliniÄŤni center Ljubljana Fluorometrična imunska metoda za določanje protiteles proti dvojnoverižni DNA
BR112017002575B1 (pt) * 2014-08-08 2023-11-07 Allegheny Singer Research Institute Método para diagnosticar especificamente lúpus sistêmico eritematoso em um indivíduo
CA2990722C (en) 2015-07-31 2022-07-05 Allegheny-Singer Research Institute Cell-bound complement activation product assays as companion diagnostics for antibody-based drugs
KR20170108203A (ko) * 2016-03-16 2017-09-27 주식회사 피플바이오 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
CN108169303B (zh) * 2017-12-07 2019-08-20 商丘师范学院 基于金属有机框架材料作为信号探针的核酸适配体电化学传感器
US20210247392A1 (en) * 2018-07-02 2021-08-12 Siemens Healthcare Diagnostics Inc. Direct immunoassay measurement of autoantibodies
JP7268306B2 (ja) * 2018-08-31 2023-05-08 東洋紡株式会社 生体試料中の測定対象物質を免疫学的に測定する方法
JP7356128B2 (ja) * 2019-06-07 2023-10-04 慶應義塾 自己免疫疾患の検出剤となるタンパク質複合体、及びその使用
CN113759107A (zh) * 2021-08-18 2021-12-07 苏州立禾生物医学工程有限公司 生物素标记缓冲液

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259207A (en) * 1979-09-19 1981-03-31 American Hospital Supply Corporation Suspending medium for immunologic reactions
JPS57182168A (en) * 1981-05-02 1982-11-09 Mitsubishi Chem Ind Ltd Immunochemical reagent
US5183735A (en) * 1989-02-27 1993-02-02 Reaads Medical Products, Inc. Method and diagnostic test kit for detection of anti-dsDNA antibodies
US5194585A (en) * 1989-04-25 1993-03-16 Igen, Inc. Inhibitors of catalytic antibodies
US5981180A (en) 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US5763158A (en) 1997-02-06 1998-06-09 The United States Of America As Represented By The Secretary Of The Army Detection of multiple antigens or antibodies
US6958244B2 (en) * 2002-04-12 2005-10-25 Bruker Biospin Corp. Low-conductivity buffers for magnetic resonance measurements
AU2004273783A1 (en) * 2003-07-12 2005-03-31 Accelr8 Technology Corporation Sensitive and rapid biodetection
EP2522755B1 (en) 2007-08-13 2014-04-02 Baxter International Inc. IVIG modulation of chemokines for treatment of Multiple Sclerosis, Alzheimer's disease, and Parkinson's disease
CA2716521A1 (en) 2008-02-29 2009-09-11 Baxter Healthcare S.A. Anti-amyloid .beta. activity of intravenous immunoglobulin (ivig) in vitro
EP2418486B1 (en) * 2009-03-05 2013-11-06 Denka Seiken Co., Ltd. Test reagent kit and its use in a method for measuring an analyte in test sample
CA2756006A1 (en) * 2009-03-31 2010-10-07 Japan Tobacco Inc. Method for detecting antibody against sith-1 in biological sample
EP2435474A2 (en) 2009-05-27 2012-04-04 Baxter International Inc A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield

Also Published As

Publication number Publication date
JP6333731B2 (ja) 2018-05-30
AU2012321074A1 (en) 2013-06-27
EP2791675B1 (en) 2018-04-25
HRP20181118T1 (hr) 2018-09-21
US20130149700A1 (en) 2013-06-13
WO2013090636A1 (en) 2013-06-20
PT2791675T (pt) 2018-07-27
ES2685332T3 (es) 2018-10-08
AR089233A1 (es) 2014-08-06
HUE038441T2 (hu) 2018-10-29
DK2791675T3 (da) 2018-07-30
AU2012321074B2 (en) 2015-12-03
US9075069B2 (en) 2015-07-07
KR20140104479A (ko) 2014-08-28
EP2791675A1 (en) 2014-10-22
JP2015500502A (ja) 2015-01-05
PL2791675T3 (pl) 2018-10-31

Similar Documents

Publication Publication Date Title
TW201339578A (zh) 在低傳導率下具有增加之靈敏度的自體抗體測量
JP7135039B2 (ja) 血漿カリクレイン系バイオマーカーを決定するためのアッセイ
O'Connor et al. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis
Fialová et al. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis
JP5711449B2 (ja) 膵島細胞抗原分子及び又はインスリンに反応する自己抗体の検出
DK2510359T3 (en) METHODS AND REAGENTS FOR IMPROVED DETECTION OF AMYLOID-BETA PEPTIDES
US20140322723A1 (en) Diabetes diagnosis through the detection of glycated proteins in urine
US20160370385A1 (en) Assay for anti-mullerian hormone
CN114573692A (zh) 用于检测嗜铬粒蛋白a的免疫测定与抗体
JP2007183176A (ja) 重症筋無力症の診断方法およびそのキット
JP2016040540A (ja) ドレブリンａ及びドレブリンｅの特異的定量法
EP3314267A1 (en) Method of detecting or monitoring an igg4-related disease by detecting igg4 kappa/lambda hybrid antibodies
US20140377883A1 (en) Peripherin-specific autoantibodies as a marker for neurological and endocrinological disease
EP3132269B1 (en) Diagnosis of chronic kidney disease by quantitative analysis of post-translational modifications of plasma proteins
US20200124612A1 (en) Detection of predictors of preeclampsia
EP3311164B1 (en) Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain
JP3510889B2 (ja) 糖尿病及び前糖尿症状の診断のための方法
WO2024014426A1 (ja) 筋炎／皮膚筋炎に伴うリスクを検出する方法
EP3491383A1 (en) Salivary abeta42 levels as prognostic indicators for alzheimer's disease
JP4774513B2 (ja) 自己免疫疾患の診断剤及び診断方法
JP2022544942A (ja) 小児患者における腎機能を診断若しくはモニタリングする、又は腎機能障害を診断する方法
CN111323597A (zh) 用于检测受试者中mci和/或ad的方法、试剂盒及筛选化合物的方法